Skip to main content
Clinical Trials/NCT02052583
NCT02052583CompletedNot Applicable

Evaluation de l'oxymétrie cérébrale à Deux Niveaux d'Hypothermie thérapeutique après arrêt Cardiaque Extra-hospitalier

Centre Hospitalier Universitaire de Nice2 sites in 1 country44 target enrollmentStarted: March 28, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
44
Locations
2
Primary Endpoint
Mesure of cerebral oximetry

Study Overview

Brief Summary

Cardiac arrest is a major public health problem, with 700 000 cases per year , and a survival ranging from 4 to 33%. The post- anoxic encephalopathy remains the most serious complication with only a third of survivors . It is due to a series of phenomena involving microcirculation disorders . Cerebral oximetry is a new technique to evaluate the microcirculatory status . To this day it is used in cardiovascular surgery at risk of cerebral hypoperfusion where desaturation of cerebral oximetry is synonymous with ischemia and microcirculatory disorders. Therapeutic hypothermia is the only treatment improves the outcome of patients after extra- hospital cardiac arrest resuscitation . Its mechanisms of action seem to change all the phenomena responsible for microcirculatory reperfusion disorders . Currently it is recommended to practice hypothermia between 32 and 34 ° C. However, a recent study suggests a superiority of hypothermia at 32 ° C rather than 34 ° C.

The hypothesis of this study is that cerebral oximetry value will be different in patients subjected to two different levels of therapeutic hypothermia in the aftermath of an extra- hospital cardiac arrest. These data allow a better understanding of the mechanisms underlying the benefit of this technique.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient presented with an extra-hospital cardiac arrest resuscitation and to benefit from therapeutic hypothermia using a servo system to its temperature (CoolGard 3000 ® system)
  • •Age> 18 years and <80 years

Exclusion Criteria

  • •Major Patient protected by law
  • •Private person administrative or judicial freedom
  • •Neurological or traumatic cause of cardiac arrest
  • •Pregnancy

Arms & Interventions

34°C

Experimental

therapeutic hypothermia at 34 ° C

Intervention: therapeutic hypothermia at 34 ° C (Procedure)

32°C

Experimental

therapeutic hypothermia at 32 ° C

Intervention: therapeutic hypothermia at 32 ° C (Procedure)

Outcomes

Primary Outcomes

Mesure of cerebral oximetry

Time Frame: 8 times during the first 48 hours of hospitalization

During the first 48 hours of hospitalization, we will collect the cerebral oximetry values in the two cerebral hemispheres.

Secondary Outcomes

  • Outcome of patients(6 months after hospitalization)
  • Mesure of lactate(4 times during the first 48 hours of hospitalization)
  • The cerebral oximetry values (average of the two hemispheres) will be compared between patients with good and poor neurological outcome.(8 times during the first 48 hours of hospitalization)
  • For each level of therapeutic hypothermia the cerebral oximetry values will be compared between patients with good and poor becoming(baseline, when target temperature is reached, 6 hours, 12 hours, 18 hours, 24 hours, when 37°C is reached)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials